The changing roles of p&t committees: a look back at the last decade and a look forward to 2020.
Market and regulatory changes in the last 10 years, as well as the Affordable Care Act, have resulted in significant modifications to health care delivery models. Traditionally, P&T committees limited the impact of their decisions to the populations associated with their hospital or health plan; however, as hospitals have begun to transform into larger health systems and even integrated payer organizations, P&T committees must consider both inpatient and outpatient needs of patients in multiple hospitals and ambulatory care settings. The function of the P&T committee has not necessarily changed, but its scope has expanded. Considerations of quality, cost (reimbursement), and access (accreditation) affecting P&T committees over the past decade will become even more important as new drugs and biotech therapies enter the market and the shortage of primary care physicians intensifies. Pharmacists, physical therapists, nurses, and physicians are assuming new leadership responsibilities, making them partners with P&T committees in improving clinical care and cost performance for health systems.
F Randy
FR
Vogenberg
Judith
J
Gomes
Affordable Care Act (ACA); P&T; access; accountable care organizations (ACOs); accreditation; biologic drugs; collaborative care; health system; hospital; leadership; nurses; pharmacists; pharmacy and therapeutics committee; physical therapists; physicians; quality of care; reimbursement models; transitions of care